Fig. 4.
Effect of unloading and sclerostin treatment on femoral strength as assessed by three-point bending, (A) maximum force, and (B) bending stiffness. Horizontal bars designate significant differences between VEH and SclAbII within loading group (p < 0.01); †p < 0.01 CON versus HLU within a treatment group.